What to know about inflammatory breast cancer
Inflammatory breast cancer is a rare and aggressive form of breast cancer with a high mortality rate. This article explains the symptoms, treatment, and prognosis of the disease. …read more
Bridging Language Gaps May Boost Outcomes
Low English proficiency puts patients with chronic conditions such as heart failure and COPD at much higher risk for returning to the hospital, new data show. Medscape Medical News …read more
Family Care for Older Inpatients Reduces Delirium
Family members can be critical allies when it comes to helping elderly patients avoid postoperative delirium, researchers found. Medscape Medical News …read more
FDA OKs Ustekinumab (Stelara) for Moderate to Severe UC
Ustekinumab was more effective than placebo for inducing and maintaining remission and promoting mucosal healing in a study of adults with moderately to severely active ulcerative colitis. FDA Approvals …read more
Suspect Lyme Carditis? Start Empiric Antibiotics
Waiting for test results before initiating therapy for patients suspected of having Lyme carditis may result in death, data from two recent cases show. Medscape Medical News …read more
FDA Clears First Topical Form of Minocycline for Acne
Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older. FDA Approvals …read more
Douching linked to dangerous chemicals in blood
Emerging evidence links vaginal douches with higher blood concentrations of potentially harmful chemicals, which may contribute to adverse health effects. …read more
Work and family demands may impact women’s heart health
A new Brazilian study has found that stress arising from balancing work and family life can detrimentally affect women’s cardiovascular health. …read more
EU Panel Backs Drugs for Hypoglycemia, Osteoporosis
After an initial no, CHMP backs romosozumab for severe osteoporosis with high fracture risk; Baqsimi is the first nasally administered treatment for severe hypoglycemia. International Approvals …read more
FDA Expands Xofluza to People at High-Risk for Flu Complications
People at high risk for serious flu complications are those with conditions such as asthma, chronic lung disease, diabetes, heart disease, morbid obesity, or adults aged 65 years or older. FDA Approvals …read more